Thermo Fisher Scientific (TMO) Other Working Capital Changes (2009 - 2020)

Thermo Fisher Scientific (TMO) has reported Other Working Capital Changes for 12 consecutive years, with -$410.0 million the latest figure, recorded in Q4 2020.

• Other Working Capital Changes for Q4 2020 came in at -$410.0 million, down 322.83% year-over-year; the trailing twelve-month figure through Dec 2020 was -$1.5 billion (down 833.33% YoY), and the FY2025 annual result was $1.3 billion, up 605.38% from the prior year.
• Other Working Capital Changes was -$410.0 million for Q4 2020 at Thermo Fisher Scientific, up from -$739.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $443.0 million in Q1 2020 and troughed at -$746.0 million in Q2 2020.
• Average Other Working Capital Changes over 5 years is -$48.0 million, with a median of $45.4 million recorded in 2016.
• Year-over-year, Other Working Capital Changes jumped 697.1% in 2017 and plunged 985.45% in 2019.
• Over 5 years, Other Working Capital Changes stood at $60.7 million in 2016, then tumbled by 231.8% to -$80.0 million in 2017, then tumbled by 146.25% to -$197.0 million in 2018, then surged by 193.4% to $184.0 million in 2019, then sank by 322.83% to -$410.0 million in 2020.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$410.0 million in Q4 2020, -$739.0 million in Q3 2020, and -$746.0 million in Q2 2020.